로딩 중…
StockDiggingStockDigging

이지바이오

353810· KOSDAQ
₩6,250-2.34%
2026-06-19

Price Chart

이지바이오+21.60%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap206.76B KRW
Revenue490.70B KRW
Net Income35.39B KRW
Total Assets361.87B KRW
Net Assets120.30B KRW
Employees134
Value
P/E5.84x
P/B1.72x
PEG0.05x
P/S0.42x
EV/EBITDA6.60x
FCF Yield5.60%
Profitability
ROE29.42%
ROA9.78%
Op. Margin10.01%
Revenue Growth11.77%
Earnings Growth110.26%
Financial Health
Debt Ratio200.81%
Total Debt162.30B KRW
FCF11.59B KRW
Cash44.77B KRW
Current Ratio1.23x
Net Debt/EBITDA2.39x
Dividend
Div. Yield3.91%
Div. Growth25.00%
Performance
1Y Return21.60%
1M Return-13.19%
From 52W High-26.99%
1Y MDD-26.43%
Trading
Volume107,341 shares
Foreign Own.6.83%
Per Share
EPS1,010 KRW
BPS3,461 KRW

Company Info

CEO 황일환, 김재원(각자대표)
Employees 134
Founded 2020
HQ 서울특별시 강남구, KR

Established in 2020 through a spin-off from Easy Holdings Co., Ltd., the company was re-listed on KOSDAQ in the same year. It specializes in manufacturing and selling animal pharmaceuticals, compound feed, and functional foods, alongside developing natural antimicrobial substances as antibiotic alternatives. The company differentiates its piglet feed with dedicated production facilities and processing technology, while developing high value-added feed additives based on fermentation engineering. Easy Bio was established in 2020 and is headquartered in Gangnam-gu, Seoul.